載入...
RANKL Inhibition Through Osteoprotegerin Blocks Bone Loss in Experimental Periodontitis
BACKGROUND: Prevention of alveolar bone destruction is a clinical challenge in periodontal disease treatment. The receptor activator of nuclear factor-kappa B ligand (RANKL) inhibitor osteoprotegerin (OPG) inhibits osteoclastogenesis and suppresses bone resorption. METHODS: To study the effects of R...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2583091/ https://ncbi.nlm.nih.gov/pubmed/17608585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1902/jop.2007.070073 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|